Petach Tikva, Israel, 05th Nov 2020 – Isotopia Molecular Imaging is pleased to announce that it has begun a collaboration with Y-mAbs Therapeutics, Inc., a
A Global marcom officer is required for a dynamic company in the Nuclear Medicine field.
We are looking to recruit an experienced global marcom officer to develop our online and offline marketing communication and to increase brand awareness.
8 Sep 2020 Isotopia Molecular Imaging and CPDC are pleased to announce that they have entered into an agreement for the production and distribution of
Isotopia Molecular Imaging ltd. is pleased to announce that it has filed a Drug Master File (DMF) with the U.S. FDA for no-carrier-added Lutetium-177 (n.c.a.
177Lu-PSMA-617 radioligand therapy in mCRPC – VISION phase 3 trial The results from the “ProPSMA” Study, that was recently published in JAMA Oncology by Prof.
The “proPSMA” study results proved the superiority of 68Ga-PSMA imaging over conventional imaging with CT and Bone Scan in Prostate Cancer Results from a randomised
Get in touch…
האתר נבנה ומקודם ע”י חברת
